![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Cornerstone Biopharma Swaps Product Lines With Adams Laboratories
Cornerstone Biopharma Swaps Product Lines With Adams Laboratories
Cornerstone BioPharma Inc. has struck a deal to transfer its Humibid family of products to Adams Laboratories Inc. Humibid is an anti-congestion drug. In exchange, Adams Laboratories will transfer the AlleRx family of prescription respiratory medications to Cornerstone BioPharma.
Triangle Business Journal (http://www.bizjournals.com/triangle/stories/2005/02/14/daily20.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct